Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Non-Current Deffered Revenue (2019 - 2025)

Historic Non-Current Deffered Revenue for AVITA Medical (RCEL) over the last 7 years, with Q4 2025 value amounting to $290000.0.

  • AVITA Medical's Non-Current Deffered Revenue fell 1049.38% to $290000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $290000.0, marking a year-over-year decrease of 1049.38%. This contributed to the annual value of $290000.0 for FY2025, which is 1049.38% down from last year.
  • Per AVITA Medical's latest filing, its Non-Current Deffered Revenue stood at $290000.0 for Q4 2025, which was down 1049.38% from $298000.0 recorded in Q3 2025.
  • Over the past 5 years, AVITA Medical's Non-Current Deffered Revenue peaked at $1.1 million during Q2 2021, and registered a low of $290000.0 during Q4 2025.
  • Moreover, its 5-year median value for Non-Current Deffered Revenue was $369500.0 (2023), whereas its average is $561750.0.
  • Per our database at Business Quant, AVITA Medical's Non-Current Deffered Revenue skyrocketed by 15287.36% in 2021 and then plummeted by 5668.93% in 2023.
  • Over the past 5 years, AVITA Medical's Non-Current Deffered Revenue (Quarter) stood at $952000.0 in 2021, then fell by 26.68% to $698000.0 in 2022, then tumbled by 48.85% to $357000.0 in 2023, then fell by 9.24% to $324000.0 in 2024, then decreased by 10.49% to $290000.0 in 2025.
  • Its Non-Current Deffered Revenue stands at $290000.0 for Q4 2025, versus $298000.0 for Q3 2025 and $307000.0 for Q2 2025.